Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Publikation

Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Wissenschaftlicher Artikel/Review - 31.07.2015

Seiffge David Julian, Hooff Robbert-JanVan, Nolte Christian H, Béjot Yannick, Turc Guillaume, Ikenberg Benno, Berge Eivind, Persike Malte, Dequatre-Ponchelle Nelly, Strbian Daniel, Pfeilschifter Waltraud, Zini Andrea, Tveiten Arnstein, Næss Halvor, Michel Patrik, Sztajzel Roman F, Luft Andreas R, Gensicke Henrik, Traenka Christopher, Hert Lisa, Scheitz Jan F, De Marchis Gian Marco, Bonati Leo H, Peters Nils, Charidimou Andreas, Werring David J, Palm Frederick, Reinhard Matthias, Niesen Wolf-Dirk, Nagao Takehiko, Pezzini Alessandro, Caso Valeria, Nederkoorn Paul J J, Kägi Georg, von Hessling Alexander, Padjen Visnja, Cordonnier Charlotte, Erdur Hebun, Lyrer Philippe A, Brouns Raf, Steiner Thorsten, Tatlisumak Turgut, Engelter Stefan T, NOACISP Study Group*

Zitation

Seiffge D, Hooff R, Nolte C, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz J, De Marchis G, Bonati L, Peters N, Charidimou A, Werring D, Palm F, Reinhard M, Niesen W, Nagao T, Pezzini A, Caso V, Nederkoorn P, Kägi G, von Hessling A, Padjen V, Cordonnier C, Erdur H, Lyrer P, Brouns R, Steiner T, Tatlisumak T, Engelter S, NOACISP Study Group*. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome. Circulation 2015; 132:1261-9.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Circulation 2015; 132

Veröffentlichungsdatum

31.07.2015

eISSN (Online)

1524-4539

Seiten

1261-9

Kurzbeschreibung/Zielsetzung

We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC).